Cardiovascular pharmacologic therapies under investigation:  2012.
Cardiovascular (CV) diseases and cerebrovascular diseases remain major causes of mortality and morbidity in the United States. Intensive efforts over the past 45 years to develop important pharmacologic treatments have reduced CV risk dramatically. Described in this article are over 150 drugs being developed to prevent and treat CV disease.
Departments of Medicine, New York Medical College/Westchester-Medical Center, Valhalla, NY 10595, USA. William_Frishman@nymc.edu
William H
WH
Frishman
Kalyana
K
Pallerla
D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use*; D015316:Genetic Therapy / Q000639:trends; D006801:Humans; D033581:Stem Cell Transplantation / Q000639:trends; D035703:Therapies, Investigational / Q000639:trends; D014612:Vaccines
D002317:Cardiovascular Agents; D015507:Drugs, Investigational; D014612:Vaccines